SOX2-mediated Upregulation of CD24 Promotes Adaptive Resistance Towards Targeted Therapy in Melanoma
International Journal of Cancer - United States
doi 10.1002/ijc.31609
Full Text
Open PDFAbstract
Available in full text
Date
October 16, 2018
Authors
Publisher
Wiley